-+ 0.00%
-+ 0.00%
-+ 0.00%

SRX GLOBAL ANNOUNCES ACTIVATION OF THE UNIVERSITY OF CALIFORNIA, DAVIS AS A CLINICAL TRIAL SITE FOR CERO THERAPEUTICS’ ONGOING PHASE 1 CERTAIN-T TRIAL OF CER-1236 IN HEMATOLOGIC MALIGNANCIES

Reuters·10/26/2026 13:05:00

Please log in to view news